319 related articles for article (PubMed ID: 17004974)
21. Tumor-associated glycoprotein expression in salivary gland mucoepidermoid carcinomas: an immunohistochemical study using the monoclonal antibody B72.3.
Roa RA; Hruban RH; McKenzie P; Richtsmeier W
Laryngoscope; 1994 Mar; 104(3 Pt 1):304-8. PubMed ID: 8127187
[TBL] [Abstract][Full Text] [Related]
22. The apocrine carcinoma of the breast. A cytological, immunohistochemical and ultrastructural study of 6 cases.
Alexiev B; Boschnakova Z; Prokopanov C
Zentralbl Pathol; 1994 Jul; 140(2):129-34. PubMed ID: 7524651
[TBL] [Abstract][Full Text] [Related]
23. α-Methylacyl-CoA racemase: a useful immunohistochemical marker of breast carcinoma with apocrine differentiation.
Nakamura H; Kukita Y; Kunimasa K; Kittaka N; Kusama H; Nakayama T; Tamaki Y; Sugiura R; Yasuda H; Hashimoto M; Yamamoto T; Imamura F; Nakatsuka SI
Hum Pathol; 2021 Oct; 116():39-48. PubMed ID: 34314764
[TBL] [Abstract][Full Text] [Related]
24. Mammary cancer antigen recognized by monoclonal antibody B72.3 in apocrine metaplasia of the human breast.
Castagna M; Nuti M; Squartini F
Cancer Res; 1987 Feb; 47(3):902-6. PubMed ID: 3542197
[TBL] [Abstract][Full Text] [Related]
25. Diminished number or complete loss of myoepithelial cells associated with metaplastic and neoplastic apocrine lesions of the breast.
Tramm T; Kim JY; Tavassoli FA
Am J Surg Pathol; 2011 Feb; 35(2):202-11. PubMed ID: 21263240
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of immunoreactivity of normal tissues from dogs, using monoclonal antibody B72.3.
Clemo FA; DeNicola DB; Zimmermann JL
Am J Vet Res; 1994 Aug; 55(8):1139-47. PubMed ID: 7978655
[TBL] [Abstract][Full Text] [Related]
27. Estrogen and progesterone receptors and anti-gross cystic disease fluid protein 15 (BRST-2) fail to distinguish metastatic breast carcinoma from eccrine neoplasms.
Wallace ML; Longacre TA; Smoller BR
Mod Pathol; 1995 Dec; 8(9):897-901. PubMed ID: 8751328
[TBL] [Abstract][Full Text] [Related]
28. Solid neuroendocrine carcinomas of the breast: metastases or primary tumors?
Richter-Ehrenstein C; Arndt J; Buckendahl AC; Eucker J; Weichert W; Kasajima A; Schneider A; Noske A
Breast Cancer Res Treat; 2010 Nov; 124(2):413-7. PubMed ID: 20872069
[TBL] [Abstract][Full Text] [Related]
29. Distinguishing breast carcinoma from Müllerian serous carcinoma with mammaglobin and mesothelin.
Kanner WA; Galgano MT; Stoler MH; Mills SE; Atkins KA
Int J Gynecol Pathol; 2008 Oct; 27(4):491-5. PubMed ID: 18753974
[TBL] [Abstract][Full Text] [Related]
30. Presence of alpha-lactalbumin, epidermal growth factor, epithelial membrane antigen, and gross cystic disease fluid protein (15,000 daltons) in breast cyst fluid.
Collette J; Hendrick JC; Jaspar JM; Franchimont P
Cancer Res; 1986 Jul; 46(7):3728-33. PubMed ID: 3486713
[TBL] [Abstract][Full Text] [Related]
31. Extramammary Paget's disease--evidence for an apocrine origin. An immunoperoxidase study of gross cystic disease fluid protein-15, carcinoembryonic antigen, and keratin proteins.
Mazoujian G; Pinkus GS; Haagensen DE
Am J Surg Pathol; 1984 Jan; 8(1):43-50. PubMed ID: 6198933
[TBL] [Abstract][Full Text] [Related]
32. The ultrastructural localization of gross cystic disease fluid protein (GCDFP-15) in breast epithelium.
Mazoujian G; Warhol MJ; Haagensen DE
Am J Pathol; 1984 Aug; 116(2):305-10. PubMed ID: 6205595
[TBL] [Abstract][Full Text] [Related]
33. PIP/GCDFP-15 gene expression and apocrine differentiation in carcinomas of the breast.
Pagani A; Sapino A; Eusebi V; Bergnolo P; Bussolati G
Virchows Arch; 1994; 425(5):459-65. PubMed ID: 7850069
[TBL] [Abstract][Full Text] [Related]
34. A 17-kDa CD4-binding glycoprotein present in human seminal plasma and in breast tumor cells.
Autiero M; Cammarota G; Friedlein A; Zulauf M; Chiappetta G; Dragone V; Guardiola J
Eur J Immunol; 1995 May; 25(5):1461-4. PubMed ID: 7774651
[TBL] [Abstract][Full Text] [Related]
35. Apocrine carcinoma of the breast. A morphologic and immunocytochemical study.
Eusebi V; Millis RR; Cattani MG; Bussolati G; Azzopardi JG
Am J Pathol; 1986 Jun; 123(3):532-41. PubMed ID: 3717305
[TBL] [Abstract][Full Text] [Related]
36. Minichromosome maintenance protein 2 is a reliable proliferative marker in breast carcinoma.
Reena RM; Mastura M; Siti-Aishah MA; Munirah MA; Norlia A; Naqiyah I; Rohaizak M; Sharifah NA
Ann Diagn Pathol; 2008 Oct; 12(5):340-3. PubMed ID: 18774496
[TBL] [Abstract][Full Text] [Related]
37. Breast carcinoma detection with a combination of radiolabeled monoclonal antibodies. Promising results from immunohistochemistry studies.
Mangili F; Sassi I; Di Rocco M; Leone BE; Garancini P; Santambrogio G
Cancer; 1996 Dec; 78(11):2334-9. PubMed ID: 8941003
[TBL] [Abstract][Full Text] [Related]
38. Autoradiographic evaluation of radiolabeled monoclonal antibody B72.3 distribution in tumor and lymph nodes of adenocarcinoma patients.
Roselli M; Hitchcock CL; Molinolo A; Milenic DE; Colcher D; Martin EW; Hinkle GH; Schlom J
Anticancer Res; 1995; 15(3):975-84. PubMed ID: 7645989
[TBL] [Abstract][Full Text] [Related]
39. Gross cystic disease fluid protein-15 as a marker for breast cancer: immunohistochemical analysis of 690 human neoplasms and comparison with alpha-lactalbumin.
Wick MR; Lillemoe TJ; Copland GT; Swanson PE; Manivel JC; Kiang DT
Hum Pathol; 1989 Mar; 20(3):281-7. PubMed ID: 2542151
[TBL] [Abstract][Full Text] [Related]
40. BigH3 protein expression as a marker for breast cancer.
Calaf GM; Echiburú-Chau C; Zhao YL; Hei TK
Int J Mol Med; 2008 May; 21(5):561-8. PubMed ID: 18425347
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
